Extensive ulcerated lesions in a patient with cutaneous myeloid sarcoma responded to twice-daily fludarabine and cytarabine regimen.

Khan, Maliha; Siddiqi, Rabbia; Curry, Jonathan L; Naqvi, Kiran

Khan, Maliha; Siddiqi, Rabbia; Curry, Jonathan L; Naqvi, Kiran.

Affiliation

Khan M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Siddiqi R; Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan.
Curry JL; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Naqvi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. Electronic address: knaqvi@mdanderson.org.

Blood Cells Mol Dis ; 69: 43-44, 2018 03.

Article in En | MEDLINE | ID: mdl-28624256

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Sarcoma, Myeloid/diagnosis; Sarcoma, Myeloid/drug therapy; Skin Neoplasms/diagnosis; Skin Neoplasms/drug therapy; Skin Ulcer/pathology; Aged; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Biomarkers; Biopsy; Bone Marrow/pathology; Cytarabine/administration & dosage; Drug Administration Schedule; Fatal Outcome; Humans; Male; Positron Emission Tomography Computed Tomography; Treatment Outcome; Vidarabine/administration & dosage; Vidarabine/analogs & derivatives

Key words

Cutaneous granulocytic sarcoma; Cutaneous myeloid sarcoma; Leukemia cutis

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Skin Ulcer / Antineoplastic Combined Chemotherapy Protocols / Sarcoma, Myeloid Limits: Aged / Humans / Male Language: En Journal: Blood Cells Mol Dis Journal subject: HEMATOLOGIA Year: 2018 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google